X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (228) 228
humans (208) 208
male (178) 178
middle aged (131) 131
female (128) 128
endocrinology & metabolism (113) 113
diabetes (84) 84
type 2 diabetes (82) 82
adult (69) 69
aged (63) 63
research (55) 55
glucose (54) 54
diabetes mellitus, type 2 - drug therapy (48) 48
risk factors (46) 46
abridged index medicus (42) 42
insulin (42) 42
animals (41) 41
hypoglycemic agents - therapeutic use (39) 39
insulin resistance (34) 34
physiological aspects (34) 34
obesity (33) 33
rats (33) 33
diabetes mellitus, type 2 - blood (32) 32
diabetes mellitus, type 2 - metabolism (32) 32
cardiac & cardiovascular systems (31) 31
blood glucose - metabolism (30) 30
body mass index (30) 30
adolescent (29) 29
care and treatment (29) 29
diabetes mellitus, type 2 - physiopathology (29) 29
glucagon-like peptide-1 (29) 29
metabolism (29) 29
analysis (28) 28
diabetes mellitus (28) 28
insulin-resistance (28) 28
dextrose (27) 27
magnetic resonance imaging (27) 27
mellitus (26) 26
treatment outcome (25) 25
diabetes mellitus, type 2 - complications (24) 24
hyperglycemia (24) 24
internal medicine (24) 24
young adult (24) 24
double-blind method (21) 21
health aspects (21) 21
risk (21) 21
cardiovascular (20) 20
clinical trials (20) 20
medicine & public health (20) 20
peripheral vascular disease (20) 20
studies (20) 20
type 1 diabetes (20) 20
cardiovascular disease (19) 19
diabetes therapy (19) 19
peptides - therapeutic use (19) 19
blood pressure (18) 18
exenatide (18) 18
metabolic syndrome (18) 18
case-control studies (17) 17
glucose metabolism (17) 17
glycated hemoglobin a - metabolism (17) 17
heart rate (17) 17
original research (17) 17
prevalence (17) 17
venoms - therapeutic use (17) 17
blood-pressure (16) 16
brain (16) 16
glycemic control (16) 16
hypoglycemic agents - administration & dosage (16) 16
patients (16) 16
peptides (16) 16
blood glucose - drug effects (15) 15
complications (15) 15
complications and side effects (15) 15
cross-sectional studies (15) 15
diagnosis (15) 15
fatty acids (15) 15
hypoglycemic agents (15) 15
hypoglycemic agents - adverse effects (15) 15
metformin (15) 15
postprandial period (15) 15
secretion (15) 15
biochemistry (14) 14
biomarkers - blood (14) 14
cardiovascular diseases (14) 14
disease (14) 14
endocrinology, diabetes and metabolism (14) 14
heart rate - drug effects (14) 14
insulin - metabolism (14) 14
metformin - therapeutic use (14) 14
myocardium - metabolism (14) 14
retrospective studies (14) 14
blood glucose - analysis (13) 13
cardiomyopathy (13) 13
child (13) 13
follow-up studies (13) 13
glucose - metabolism (13) 13
heart-disease (13) 13
liraglutide (13) 13
netherlands - epidemiology (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2008, Volume 52, Issue 22, pp. 1793 - 1799
Journal Article
The Lancet, ISSN 0140-6736, 09/2010, Volume 376, Issue 9746, p. 1053
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9746, pp. 1053 - 1053
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9833, pp. 2220 - 2221
Journal Article
Diabetes Care, ISSN 0149-5992, 11/2016, Volume 39, Issue 11, pp. 2042 - 2050
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 10/2014, Volume 37, Issue 10, pp. 2763 - 2773
OBJECTIVE: Mealtime insulin is commonly added to manage hyperglycemia in type 2 diabetes when basal insulin is insufficient. However, this complex regimen is... 
CONTROLLED-TRIAL | GLYCEMIC CONTROL | ORAL-THERAPY | COMBINATION THERAPY | PARALLEL-GROUP | EXENATIDE | ENDOCRINOLOGY & METABOLISM | OPEN-LABEL | TREATED PATIENTS | TREATMENT SATISFACTION | GETGOAL-L | Glycated Hemoglobin A - analysis | Hypoglycemia - epidemiology | Humans | Middle Aged | Body Weight - drug effects | Male | Hyperglycemia - drug therapy | Metformin - adverse effects | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Venoms - administration & dosage | Female | Metformin - administration & dosage | Hypoglycemia - chemically induced | Meals | Receptors, Glucagon - agonists | Drug Administration Schedule | Venoms - adverse effects | Insulin - administration & dosage | Treatment Outcome | Insulin Lispro - administration & dosage | Blood Glucose - drug effects | Insulin, Long-Acting - adverse effects | Diabetes Mellitus, Type 2 - blood | Insulin, Long-Acting - administration & dosage | Glucagon-Like Peptide-1 Receptor | Insulin Glargine | Insulin Lispro - adverse effects | Quality of Life | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Peptides - adverse effects | Type 2 diabetes | Care and treatment | Dosage and administration | Hypoglycemia | Insulin | Weight gain | Health aspects | Risk factors | Diabetes | Glucose | Medical treatment | Quality of life | Index Medicus
Journal Article
Diabetes, ISSN 0012-1797, 2014, Volume 63, Issue 12, pp. 4186 - 4196
Gut-derived hormones, such as GLP-1, have been proposed to relay information to the brain to regulate appetite. GLP-1 receptor agonists, currently used for the... 
HIGH-CALORIE | GLUCAGON-LIKE PEPTIDE-1 | FOOD-INTAKE | GLUCOSE | EXENATIDE | ENDOCRINOLOGY & METABOLISM | ENERGY-INTAKE | OPEN-LABEL | WEIGHT | ORBITOFRONTAL CORTEX | PROMOTES SATIETY | Amygdala - drug effects | Receptors, Glucagon - antagonists & inhibitors | Putamen - physiology | Humans | Middle Aged | Male | Peptide Fragments - pharmacology | Diabetes Mellitus, Type 2 - metabolism | Brain - physiology | Case-Control Studies | Cerebral Cortex - metabolism | Brain - metabolism | Prefrontal Cortex - drug effects | Adult | Female | Appetite - physiology | Cerebral Cortex - drug effects | Receptors, Glucagon - agonists | Amygdala - metabolism | Appetite - drug effects | Putamen - drug effects | Feeding Behavior - physiology | Feeding Behavior - drug effects | Hypoglycemic Agents - pharmacology | Obesity - metabolism | Peptides - pharmacology | Brain - drug effects | Cross-Over Studies | Magnetic Resonance Imaging | Functional Neuroimaging | Glucagon-Like Peptide-1 Receptor | Prefrontal Cortex - metabolism | Cerebral Cortex - physiology | Aged | Venoms - pharmacology | Reward | Photic Stimulation | Amygdala - physiology | Prefrontal Cortex - physiology | Receptors, Glucagon - physiology | Putamen - metabolism | Type 2 diabetes | Care and treatment | Brain research | Analysis | Appetite depressants | Dosage and administration | Glycemic index | Research | Obesity | Brain | Nuclear magnetic resonance--NMR | Diabetes | Hormones | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article